Bamco Inc Repligen Corp Transaction History

Bamco Inc

$32.9 Billion
Q1 2025

A detailed history of Bamco Inc transactions in Repligen Corp stock. As of the latest transaction made, Bamco Inc holds 204,969 shares of RGEN stock, worth $25.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

204,969

Previous 160,227 27.92%

Holding current value

$25.1 Million

Previous $23.1 Million 13.08%

% of portfolio

0.08%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$127.24 - $174.24 $5.69 Million - $7.8 Million	44,742 Added 27.92%	204,969 $26.1 Million
Q4 2024 Feb 14, 2025	SELL	$123.41 - $160.92 $838,200 - $1.09 Million	-6,792 Reduced 4.07%	160,227 $23.1 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $658,246 - $919,588	-5,495 Reduced 3.19%	167,019 $24.9 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $25.1 Million - $38.2 Million	-208,772 Reduced 54.75%	172,514 $21.7 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $11 Million - $13.4 Million	-64,472 Reduced 14.46%	381,286 $70.1 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $1.49 Million - $2.41 Million	-13,026 Reduced 2.84%	445,758 $80.1 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $13.8 Million - $17.6 Million	99,763 Added 27.79%	458,784 $73 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $19.1 Million - $24.9 Million	138,047 Added 62.47%	359,021 $50.8 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $32.8 Million - $42.1 Million	212,374 Added 2469.47%	220,974 $37.2 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $292,356 - $397,008	1,800 Added 26.47%	8,600 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.09 Million - $1.74 Million	6,800 New	6,800 $1.27 Million

Others Institutions Holding RGEN

# of Institutions

494

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.8B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account